Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate

被引：7

作者：

Wozniak, Marta ^{[1
]}

Pastuch-Gawolek, Gabriela ^{[2
,3
]}

Makuch, Sebastian ^{[1
]}

Wisniewski, Jerzy ^{[4
]}

Ziolkowski, Piotr ^{[1
]}

Szeja, Wieslaw ^{[2
]}

Krawczyk, Monika ^{[2
,3
]}

Agrawal, Siddarth ^{[1
,5
]}

机构：

[1] Wroclaw Med Univ, Dept Pathol, Marcinkowskiego 1, PL-50368 Wroclaw, Poland

[2] Silesian Tech Univ, Dept Organ Chem Bioorgan Chem & Biotechnol, Fac Chem, Krzywoustego 4, PL-44100 Gliwice, Poland

[3] Silesian Tech Univ, Biotechnol Ctr, Krzywoustego 4, PL-44100 Gliwice, Poland

[4] Wroclaw Med Univ, Dept Med Biochem, Marcinkowskiego 1, PL-50368 Wroclaw, Poland

[5] Wroclaw Med Univ, Dept & Clin Internal Med Occupat Dis Hypertens &, Marcinkowskiego 1, PL-50368 Wroclaw, Poland

来源：

PHARMACEUTICALS | 2021年 / 14卷 / 01期

关键词：

glycoconjugates; tumor microenvironment; methotrexate conjugate; hypoxia; cancer;

D O I：

10.3390/ph14010013

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The oxygen and nutrient-deprived tumor microenvironment is considered a key mechanism responsible for cancer resistance to chemotherapy. Methotrexate (MTX) is a widely incorporated chemotherapeutic agent employed in the treatment of several malignancies. However, drug resistance and systemic toxicity limit the curative effect in most cases. The present work aimed to design, synthesize, and biologically evaluate a novel glucose-methotrexate conjugate (Glu-MTX). Our study showed that Glu-MTX exerts an increased cytotoxic effect on cancer cells in comparison to MTX in hypoxia (1% O-2) and glucose starvation conditions. Furthermore, Glu-MTX was found to inhibit the proliferation and migration of cancer cells more effectively than MTX does. Our results demonstrate that the conjugation of MTX to glucose led to an increase in potency against malignant cells under oxygen and nutrient stress. The observations shed light on a potential therapeutic approach to overcome chemoresistance in cancer.

引用

页码：1 / 16

页数：16

共 46 条

[1] A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis
Abolmaali, Samira Sadat
Tamaddon, Ali Mohammad
Dinarvand, Rassoul
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1115 - 1130
[2] Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development
Agarwal, Paresh
Bertozzi, Carolyn R.
[J]. BIOCONJUGATE CHEMISTRY, 2015, 26 (02) : 176 - 192
[3] STRUCTURAL REQUIREMENTS FOR BINDING TO SUGAR-TRANSPORT SYSTEM OF HUMAN ERYTHROCYTE
BARNETT, JEG
HOLMAN, GD
MUNDAY, KA
[J]. BIOCHEMICAL JOURNAL, 1973, 131 (02) : 211 - 221
[4] Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Barron, Carly C.
Bilan, Philip J.
Tsakiridis, Theodoros
Tsiani, Evangelia
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (02): : 124 - 139
[5] The Warburg effect and drug resistance
Bhattacharya, Bhaskar
Omar, Mohd Feroz Mohd
Soong, Richie
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (06) : 970 - 979
[6] Glucose conjugation for the specific targeting and treatment of cancer
Calvaresi, Emilia C.
Hergenrother, Paul J.
[J]. CHEMICAL SCIENCE, 2013, 4 (06) : 2319 - 2333
[7] Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, Jason R.
Sabatini, David M.
[J]. CANCER DISCOVERY, 2012, 2 (10) : 881 - 898
[8] The tumor microenvironment is a dominant force in multidrug resistance
Correia, Ana Luisa
Bissell, Mina J.
[J]. DRUG RESISTANCE UPDATES, 2012, 15 (1-2) : 39 - 49
[9] Nonclassical Routes for Amide Bond Formation
de Figueiredo, Renata Marcia
Suppo, Jean-Simon
Campagne, Jean-Marc
[J]. CHEMICAL REVIEWS, 2016, 116 (19) : 12029 - 12122
[10] GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters
Deng, Dong
Yan, Nieng
[J]. PROTEIN SCIENCE, 2016, 25 (03) : 546 - 558

← 1 2 3 4 5 →